Quick Takeaways
- WASATCH ADVISORS LP filed SCHEDULE 13G/A for Journey Medical Corp COM (DERM).
- Disclosed ownership: 10%.
- Date of event: 31 Mar 2026.
WASATCH ADVISORS LP - 31 Mar 2026 SCHEDULE 13G/A Report for Journey Medical Corp COM (DERM)
- Filing Manager
- WASATCH ADVISORS LP
- Reporting Manager
- Wasatch Advisors LP
- Security
- Journey Medical Corp COM
- Symbol
- DERM
- Shares outstanding
- 21,333,700 shares
- Disclosed Ownership
- 2,133,370 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G/A
- Filing time
- 06 Apr 2026, 17:54:53 UTC
- Date of event
- 31 Mar 2026
- Previous filing
- 14 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"WASATCH ADVISORS LP disclosed 10% ownership in Journey Medical Corp COM (DERM) on 31 Mar 2026."
What Changed
- Previous schedule filing date: 14 Aug 2025.
- Current filing was accepted on 06 Apr 2026, 17:54.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Wasatch Advisors LP | 10% | 2,133,370 | 1,979,366 | 0 | Mike Yeates | CEO |